1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone has been researched along with loxiglumide in 2 studies
Studies (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Trials (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Recent Studies (post-2010) (1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone) | Studies (loxiglumide) | Trials (loxiglumide) | Recent Studies (post-2010) (loxiglumide) |
---|---|---|---|---|---|
26 | 0 | 5 | 257 | 54 | 9 |
Protein | Taxonomy | 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone (IC50) | loxiglumide (IC50) |
---|---|---|---|
Cholecystokinin receptor type A | Homo sapiens (human) | 0.195 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hashimoto, S; Inoue, T; Izumi, T; Koyama, T; Ohmori, T; Tsuchiya, K | 1 |
Izumi, T | 1 |
2 other study(ies) available for 1-(4-bromophenylaminocarbonyl)-4,5-diphenyl-3-pyrazolidinone and loxiglumide
Article | Year |
---|---|
Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Fear; Hormone Antagonists; Male; Proglumide; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Stress, Physiological | 1996 |
[Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
Topics: Animals; Anxiety; Biogenic Monoamines; Brain; Cholecystokinin; Disease Models, Animal; Hormone Antagonists; Male; Proglumide; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin | 1998 |